Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

24

Revenue 2017

Daiichi Sankyo

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Daiichi Sankyo's 2012 sales performance.

Daiichi Sankyo

Astellas, Catalyst approvals set up record year for FDA approvals

Astellas, Catalyst approvals set up record year for FDA approvals

Others are however moving through the late-stage pipeline, including Daiichi Sankyo’s quizartinib and Arog Pharma’s crenolanib.

The Healthcare Partnership is launched

The Healthcare Partnership is launched The company is headed by founder Duane Lacey (pictured), who has over 20 years’ experience within the industry having served in various roles for companies including AstraZeneca, Daiichi-Sankyo and Alliance

Roche preps new Kadcyla filings after phase 3 trial win

Roche preps new Kadcyla filings after phase 3 trial win Meanwhile, moving Kadcyla up the treatment pathway should help keep the ADC – currently the smallest product of the three – ahead of emerging rivals, such as  Daiichi-Sankyo’s ADC trastuzumab deruxtecan

Daiichi-Sankyo takes rival to Roche’s Kadcyla into phase 3

Daiichi-Sankyo takes rival to Roche’s Kadcyla into phase 3 If successful in phase 3, Daiichi-Sankyo’s drug could muscle into Kadcyla’s territory and provide another line of HER2 treatment in Kadcyla non-responders. ... therapy in patients with HER2 positive metastatic breast cancer,” said Gilles Gallant,

Cello poaches Astellas' Taylor, Con Franklin joins Ketchum, Uptake Strategies expands

Cello poaches Astellas' Taylor, Con Franklin joins Ketchum, Uptake Strategies expands She has also served in various positions for Daiichi Sankyo, Novartis, Eli Lilly and GlaxoSmithKline.

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Virgo Health

Virgo Health is an award-winning global healthcare communications and medical education agency comprising specialists with some of the best skills,...

Latest intelligence

Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...
Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...

Infographics